Search Results - Papi A
- Showing 1 - 7 results of 7
-
1
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal by Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B
Published in International Journal of COPD (2018-12-01)Get full text
Article -
2
-
3
The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset by Calverley PMA, Papi A, Page C, Rogliani P, Dal Negro RW, Cazzola M, Cicero AF, Wedzicha JA
Published in International Journal of COPD (2022-08-01)Get full text
Article -
4
COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US by Martinez FJ, Papi A, Welte T, Singh D, Galkin DV, Guasconi A, Pirondi S, Georges G, Imperato J, Hermans R
Published in International Journal of COPD (2024-06-01)Get full text
Article -
5
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD by Tse G, Emmanuel B, Ariti C, Bafadhel M, Papi A, Carter V, Zhou J, Skinner D, Xu X, Müllerová H, Price D
Published in International Journal of COPD (2023-11-01)Get full text
Article -
6
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD by Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB
Published in International Journal of COPD (2020-11-01)Get full text
Article -
7
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipro... by Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G
Published in Pragmatic and Observational Research (2024-01-01)Get full text
Article
